KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Change in Cash (2016 - 2025)

Historic Change in Cash for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $118.8 million.

  • West Pharmaceutical Services' Change in Cash rose 16577.18% to $118.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.6 million, marking a year-over-year increase of 13375.03%. This contributed to the annual value of -$369.3 million for FY2024, which is 81410.89% down from last year.
  • Per West Pharmaceutical Services' latest filing, its Change in Cash stood at $118.8 million for Q3 2025, which was up 16577.18% from $105.5 million recorded in Q2 2025.
  • West Pharmaceutical Services' 5-year Change in Cash high stood at $165.3 million for Q4 2022, and its period low was -$252.1 million during Q1 2024.
  • Its 5-year average for Change in Cash is $684210.5, with a median of $10.5 million in 2022.
  • In the last 5 years, West Pharmaceutical Services' Change in Cash soared by 87428.57% in 2023 and then crashed by 305125.0% in 2024.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Change in Cash stood at $74.6 million in 2021, then surged by 121.58% to $165.3 million in 2022, then crashed by 127.04% to -$44.7 million in 2023, then surged by 85.91% to -$6.3 million in 2024, then soared by 1985.71% to $118.8 million in 2025.
  • Its Change in Cash stands at $118.8 million for Q3 2025, versus $105.5 million for Q2 2025 and -$80.4 million for Q1 2025.